Marijuana Stocks & Publicly Traded Cannabis Companies

Marijuana firm Tilray revenue up nearly 200% in Q1; net loss grows on spending

Tilray, a British Columbia, Canada-based cannabis cultivator and distributor, reported revenue of $23 million for the first quarter of 2019, up 195% from the same period last year. The company’s net loss, however, widened nearly sixfold on higher spending. Tilray, which reports its earnings in U.S. dollars, said in a news release the sales gain […]

Read More

CannTrust’s Q1 revenue doubles on medical marijuana sales; net income up

Ontario, Canada-based CannTrust Holdings reported that first-quarter revenue more than doubled from a year earlier, mostly on the back of rising medical marijuana sales, while the company’s net income inched higher. Adult-use sales, however, struggled. First-quarter revenue jumped 115% from a year earlier to 16.9 million Canadian dollars ($12.6 million), thanks to strength in the […]

Read More

Acreage to sell cannabis real estate assets to newly formed REIT

New York-based marijuana company Acreage Holdings said it agreed to sell cannabis-related real estate to a newly formed real estate investment trust (REIT), GreenAcreage Real Estate Corp., under a leaseback agreement between the two companies. The price wasn’t disclosed. Acreage holds a 20% interest in GreenAcreage Real Estate Corp. (GARE). Acreage CEO Kevin Murphy also […]

Read More

Marijuana company Columbia Care reports improved Q1 revenue, wider net loss

Columbia Care, a New-York based vertically integrated cannabis operator, reported revenue of $12.9 million for the first quarter ended March 31, 2019, up 45% from the same period last year thanks to “organic growth” and stronger consumer demand for its products. The net loss for the quarter widened to $25.1 million compared with a $9.7 […]

Read More

Cannabis firm Harvest Health closes $100 million tranche of private placement

Multistate marijuana firm Harvest Health & Recreation (CSE: HARV) closed the initial tranche of its previously announced private placement for gross proceeds of $100 million. The Arizona-based company plans to use the net proceeds to cover working capital and for other general corporate costs, according to a news release. Under terms of the financing, Harvest […]

Read More

Cannabis firm Cronos Group misses on revenue, reports wider Q1 loss

Toronto-based Cronos Group reported first-quarter results Thursday revealing the licensed marijuana company’s losses grew from a year ago as it missed revenue expectations. Cronos reported first-quarter revenue of 6.5 million Canadian dollars ($4.8 million) for the period ended March 31 – up 120% from the year-ago period, the company said in a news release. The […]

Read More

Epidiolex, Sativex maker GW Pharmaceuticals reports Q1 revenue, loss improvement

United Kingdom-based GW Pharmaceuticals showed revenue of $39.2 million for the quarter ended March 31, 2019, compared with $3 million in the same period a year ago. The maker of cannabis-derived medications, including Sativex and Epidiolex, recorded a net loss for the quarter of $50.1 million compared with a year-ago net loss of $69.5 million. […]

Read More

Multistate marijuana firm Curaleaf to expand into Ohio with $20 million acquisition

Massachusetts-based Curaleaf, which last week agreed to acquire Cura Partners for almost $1 billion, will expand into Ohio with the purchase of Ohio Grown Therapies. The $20 million deal, expected to close in the second half of 2019, includes the acquisition of Johnstown-based Ohio Grown Therapies’ cultivation and processing facilities and licenses. For more details, click […]

Read More